#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Synovial sarcoma metastatic Desmoid tumour Glomerulonephritis acute Cerebral haemorrhage Systemic lupus erythematosus Polyneuropathy Acute graft versus host disease in skin Neuroendocrine tumour of the lung Biliary neoplasm Malformation venous Friedreich's ataxia Prodromal Alzheimer's disease Ewing's sarcoma Cluster headache Piriformis syndrome More trials…

    Learn about Rare Diseases

    Ewing’s sarcoma – Life with Disease Alveolar rhabdomyosarcoma – Treatment Nephroblastoma – Life with Disease Choroid melanoma – Trials in Disease Waldenstrom’s macroglobulinaemia – Life with Disease Adrenocortical carcinoma – Life with Disease Soft tissue sarcoma – Trials in Disease Marginal zone lymphoma refractory – Basic Information Haemolytic uraemic syndrome – Basic Information Mantle cell lymphoma stage III – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Temsirolimus Pralsetinib ADS-019 Plasma Ro7589655 Avatrombopag Eo2317 Sodium Iotalamate (125I) Proguanil Hydrochloride Decitabine Utreloxastat Gabapentin Fosamprenavir Calcium Tirbanibulin STREPTOCOCCUS VIRIDANS Sparsentan Gadobenate Dimeglumine Amlitelimab Florbetaben (18F) Valaciclovir More therapies…

    Learn about Your Condition

    Herpes virus infection Mastocytosis Ocular hypertension Alpha-1 antitrypsin deficiency Death neonatal Marginal zone lymphoma Essential hypertension Colitis Pouchitis Muscle injury Optic ischaemic neuropathy Angina pectoris Dementia Alzheimer's type Metastases to peritoneum Arthroscopy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Testing continuous versus intermittent treatment with cetuximab, fluorouracil, folinic acid, and irinotecan in patients with newly diagnosed metastatic colorectal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Cetuximab
    • Fluorouracil
    • Folinic Acid
    Germany

  • A study of mirdametinib for infants and toddlers under 24 months of age with neurofibromatosis type 1 associated plexiform neurofibromas

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Neurofibromatosis
    Germany Spain

  • A Study of Ivosidenib and Azacitidine for Patients Over 55 with Acute Myeloid Leukemia and IDH1 Mutation in Complete Remission

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France

  • Study comparing stellate ganglion block with bupivacaine and lidocaine versus amiodarone for patients with electrical storm of the heart

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Bupivacaine Hydrochloride
    • Amiodarone Hydrochloride
    • Lidocaine Hydrochloride Monohydrate
    Italy

  • Testing avacopan added to standard treatment in patients with ANCA-associated vasculitis with severe kidney damage

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Anti-neutrophil cytoplasmic antibody positive vasculitis
    Investigated Drugs:
    • Avacopan
    • Cyclophosphamide
    • Methylprednisolone
    France

  • A Study of Obecabtagene Autoleucel for Patients with Severe Lupus and Active Kidney Inflammation Not Responding to Standard Treatment

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lupus nephritis
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Autologous Enriched T Cells Retrovirally Transduced To Express Two Chimeric Antigen Receptors Targeting Cd19 And Cd22
    • Fludarabine Phosphate
    • Cyclophosphamide
    Greece
Previous Page
1 … 757 758 759 760 761 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!